This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernard, K. Articles by Resing, K. A. Search for Related Content PubMed PubMed Citation Articles by Bernard, K. Articles by Resing, K. A.

Functional Proteomic Analysis of Melanoma Progression¹

Department of Chemistry and Biochemistry [K. B., G. A., K. A. R., N. G. A.] and Howard Hughes Medical Institute [E. L., K. P., N. G. A.], University of Colorado, Boulder, Colorado 80309; Department of Dermatology, School of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262 [J. L. F., Y. G. S., D. A. N.]; Department of Pediatrics, School of Medicine, University of Virginia, Charlottesville, Virginia 22908 [A. D. E.]; and Department of Cell Biology, University of Cincinnati, Cincinnati, Ohio 45267 [K. F.]

Functional proteomics provides a powerful approach to screen for alterations in protein expression and posttranslational modifications under conditions of human disease. In this study, we use protein screening to examine markers of melanoma progression, by profiling melanocyte versus melanoma cell lines using two-dimensional electrophoresis and mass spectrometry. Eight candidate markers were identified as differentially regulated in transformed cells. In particular, hepatoma-derived growth factor (HDGF) and nucleophosmin B23 were strongly correlated with melanoma. Nucleophosmin B23 is a nucleolar and centrosome-associated protein, which has been implicated as a target for cyclin E/cyclin-dependent kinase 2 (CDK2) in modulating centrosome duplication and cell cycle control. Western blotting of one-dimensional and two-dimensional gels showed that the form of nucleophosmin B23 that is up-regulated in melanoma represents a posttranslationally modified form, most likely reflecting enhanced phosphorylation in the tumor-derived cells. In contrast, Western analysis of HDGF demonstrated increased expression of all forms in melanoma cell lines compared with melanocytes. Immunohistochemical analysis of human tissue biopsies showed strong expression of HDGF in early and late stage melanomas and low expression in melanocytes and nontumorigenic nevi. Interestingly, biopsies of nevi showed a graded effect in which HDGF immunoreactivity was reduced in nevoid nests penetrating deep into the dermis compared with nests at the epidermal-dermal junction, suggesting that HDGF expression in nevi is dependent on epidermal cell interactions. In contrast, biopsies of melanoma showed strong expression of HDGF throughout the tumor, including cells located deeply within dermis. Thus, expression of this antigen likely reports a reduced dependence of protein expression on epidermal interactions.

This article has been cited by other articles:

				B. Falini, I. Nicoletti, N. Bolli, M. P. Martelli, A. Liso, P. Gorello, F. Mandelli, C. Mecucci, and M. F. Martelli Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias Haematologica, April 1, 2007; 92(4): 519 - 532. [Abstract] [Full Text] [PDF]

				J. Zhang, H. Ren, P. Yuan, W. Lang, L. Zhang, and L. Mao Down-regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non-Small Cell Lung Cancer Cells Cancer Res., January 1, 2006; 66(1): 18 - 23. [Abstract] [Full Text] [PDF]

				M. M. Abouzied, H. M. El-tahir, L. Prenner, H. Haberlein, V. Gieselmann, and S. Franken Hepatoma-derived Growth Factor: SIGNIFICANCE OF AMINO ACID RESIDUES 81-100 IN CELL SURFACE INTERACTION AND PROLIFERATIVE ACTIVITY J. Biol. Chem., March 25, 2005; 280(12): 10945 - 10954. [Abstract] [Full Text] [PDF]

				P. Carter, L. Smith, and M. Ryan Identification and validation of cell surface antigens for antibody targeting in oncology Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687. [Abstract] [Full Text] [PDF]

				T. W. Young, F. C. Mei, G. Yang, J. A. Thompson-Lanza, J. Liu, and X. Cheng Activation of Antioxidant Pathways in Ras-Mediated Oncogenic Transformation of Human Surface Ovarian Epithelial Cells Revealed by Functional Proteomics and Mass Spectrometry Cancer Res., July 1, 2004; 64(13): 4577 - 4584. [Abstract] [Full Text] [PDF]